As requested by the AHA, the Centers for Medicare & Medicaid Services yesterday said it will continue to remain flexible in its approach to surveys if a hospital experiences a COVID-19 surge.

“Hospitals in these circumstances should notify their State Survey Agency as soon possible, who will then coordinate with their CMS Location to consider a short-term, hospital-specific survey suspension,” CMS said. “This communication should be prior to any survey activity. Once surveyors are onsite at a hospital, they will not be recalled.” 

In evaluating whether to temporarily suspend survey activities, CMS said it will consider whether the hospital has notified the appropriate state public health agency and activated its emergency preparedness plan, and the proportion of hospital staff and resources dedicated to managing COVID-19 patients.  
 

Related News Articles

Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National…
Headline
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-…